Shares of Praxis Precision Medicines (NASDAQ: PRAX) leaped on Monday after the clinical-stage biopharmaceutical company received a Breakthrough Therapy Designation (BTD) for its experimental tremor treatment.

By the close of trading, Praxis' stock price was up more than 13%.

Image source: Getty Images.

Continue reading

Source Fool.com